Stroke Diagnostics and Therapeutics Market by Type - Global Industry Analysis and Forecast to 2025

Report Code : HC0689

A stroke is sudden death of brain cells. Stroke occurs when the blood flow to the brain is blocked by clot in brain artery. These clots can travel through blood and get deposited in the artery of brain causing complete blockage and thereby restricting oxygen and blood flow to brain. Stroke is of two types: ischemic (due to lack of blood flow) and hemorrhagic (due to internal bleeding in brain). Signs and symptoms of stroke depend on the area of brain which is affected and characterized by weakness or paralysis of the body with complete or partial loss of voluntary movements and sensations in various parts of body especially in legs and arms. Stroke that affects base of the brain can lead to blurring of vision, uneasiness in breathing and even result in unconsciousness.

A stroke can be clinically diagnosed either through patient’s medical history or by conducting scans in order to detect possible cause of stroke for timely treatment to patients. Therapeutics drugs such as anticoagulants are most commonly used to treat stroke and related symptoms by reducing blood clot. Ischemic strokes can only be treated with tissue plasminogen activator (only approved treatment by FDA). Brain clots can also be removed through mechanical procedures known as thrombectomy. In this procedure clot is removed with the help of wire-cage device called as stent retriever. Although controlling internal bleeding during hemorrhagic stroke is difficult, it can be minimized through a catheter which is attached to brain tissue through major artery in an arm or leg. Sometime surgical procedures are required to remove large clots from brain tissues.

Increasing geriatric population, high obesity rate and increasing prevalence of chronic diseases are expected to increase demand for stroke diagnosis and therapeutic market. In addition to unhealthy diet, high glucose and cholesterol level and increasing prevalence of hypertension will further drive the global market. According to American Heart Association, approximately 800,000 people in the U.S. alone suffer from stroke every year with three out of four being first time strokes. Such a high prevalence of stroke worldwide will further drive the growth of the global market. However, high cost of medical treatment and unfavorable reimbursement policies will possess some challenge for the growth of the market.

Key players operating in the global stroke diagnostics and therapeutics market include Abbott Laboratories, Siemens AG, Stryker Corporation, and GE Healthcare, Medtronic plc. Cordis Corporation, Genentech Inc., Boston Scientific Corporation, Coaxia Inc. and Philips Healthcare. These key players are focusing on acquiring large customer base through launch of new products that enhances interventional cardiology care. For instance, Cordis in 2017 has launch three new products- Cordis RAILWAY Sheathless Access System, Ikazuchi Zero and Raiden 3 PTCA balloons for expanding their product portfolio and to gain competitive advantage. These devices have ability to directly access radial artery thereby eliminating the need of an introducer sheath.

Advancements in therapeutic strategies such as stroke unit care and treatments including plasminogen activator (tPA) will propel growth of the market in coming years. Plasminogen activator is group of enzymes used for clot busting used in treatment of heart attack and stroke. Plasminogen activator catalyzes conversion of plasminogen to plasmin (enzyme for breaking clot). Although currently available thrombolytic therapies have significantly reduced mortality, however there is need for large therapeutic doses and limited fibrin specificity. To address problems associated with available plasminogen activator, major players are focusing on development of newer agents especially biotechnologically engineered thrombolytic agents for better outcomes. Extensive research and development will lead to development of novel therapeutic drugs, thereby providing ample opportunities for market players to adopt such developments to gain competitive advantage and larger market share.

Stroke Diagnostics and Therapeutics Market Segmentation:

By Diagnostics

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography Scan (CT scan)
  • Electrocardiography
  • Carotid Ultrasound
  • Cerebral Angiography
  • Others

By Therapeutics

  • Tissue Plasminogen Activator
  • Antiplatelet
  • Antihypertensive
  • Anticoagulant

By Application

  • Hemorrhagic Stroke
  • Ischemic Stroke

By Region

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • Turkey
  • United Arab Emirates
  • Others

 

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Licesnces Type

For Any Further Assistance

*
*
*